You searched for Antibody candidate - Page 9 of 69

News and Trends 31 May 2017

German Biotech Enters the Clinic with Next-Generation Antibody for AML

…immunotherapy candidate, TacSyn, to treat patients at a stage of existing disease of AML as well as acute lymphoblastic leukemia (ALL). This bispecific antibody contains an anti-CD3 domain, which is…

May 31, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 8 May 2017

The EU Approves New Treatment for a Rare Pediatric Cancer

…Human Use (CHMP) has now given a positive opinion on APN311, recommending the approval of the new drug. APN311 is a monoclonal antibody targeting the neuroblastoma-specific antigen GD2. The antibody…

May 8, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 11 Oct 2016

UK Upstart to sign Huge Deal with Takeda in End Run around Antibody Therapies

…unabridged antibody counterparts, almost comparable to small peptides. Figure 1. A diagram of a whole antibody – Humabodies whittle these down to just the VH domain reflecting the antibody binding…

October 11, 2016 - 3 minutesmins - By Evelyn Warner

Interview 12 Feb 2018

MorphoSys’ CEO Tells Us What’s Next for Europe’s Antibody Expert

…those compounds,” he continued. MorphoSys’ first attempt at taking its own antibody to market will be with its blood cancer candidate, MOR208, a monoclonal antibody that targets CD19, which is…

February 12, 2018 - 8 minutesmins - By Alex Dale

novimmune shire hemophilia antibody roche

News and Trends 18 Jul 2017

Shire In-Licenses Swiss Antibody for Hemophilia A to Compete with Roche

Shire has bought exclusive worldwide rights to develop and commercialize a bispecific antibody from Novimmune that could improve the treatment of hemophilia A. Novimmune is a biotech from Geneva that…

July 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Jul 2023

Epsilogen completes first clinical trial of IgE antibody to treat cancer

…results were published in Nature Communications. MOv18 IgE is Epsilogen’s lead IgE antibody drug candidate and binds to anti-folate receptor (FRα), a well validated target for ovarian cancer. It was…

July 27, 2023 - 2 minutesmins - By Jim Cornall

morphosys thrombosis phaseI novartis hucal

News and Trends 4 Jul 2016

Novartis delivers German Biotech’s 12th Antibody to Clinics

MorphoSys keeps up its impressive productivity in feeding pipelines. Its 12th antibody in its Novartis collaboration has just reached clinical development. After presenting results for two of its wholly-owned candidates…

July 4, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 13 Apr 2017

Next-Gen Cancer Antibody Technology from Germany enters the Clinic

Apogenix’ partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the potential to outperform antibody therapy. The German biotech Apogenix has announced that its partner AbbVie…

April 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 7 Jun 2017

What Cancer Therapies did European Biotechs Showcase at ASCO 2017?

…competitors, BMS, MSD and Roche, in the coveted PD-L1 / PD-1 checkpoint inhibitor space. The Danish antibody giant Genmab presented a Phase I/IIa update on HuMax-AXL-ADC, an antibody-drug conjugate (ADC)…

June 7, 2017 - 5 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 20 Dec 2021

The Billion-Euro European Biotech Companies in 2022

…of antibody treatments for cancer and inflammatory and autoimmune diseases. Its first antibody, Tremfya, a treatment for psoriasis, was launched in 2017 in collaboration with Janssen. The company has ongoing…

December 20, 2021 - 12 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 20 Nov 2023

M&As: what’s up with the ADC buying spree?

…biotech Orum Therapeutics’ ADC candidate is proof of this. The anti-CD33 antibody-enabled GSPT1 degrader, ORM-6151, received U.S. Food and Drug Administration (FDA) clearance to pursue phase 1 trials for treating…

November 20, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 6 Jun 2017

French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug

…Pharma has in-licensed a new clinical-stage antibody candidate from Novo Nordisk to reinforce its position in the crowded space. In exchange for its anti-C5aR antibody, IPH5401, Novo Nordisk gets a…

June 6, 2017 - 2 minutesmins - By Melanie De Almeida

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

German Biotech Enters the Clinic with Next-Generation Antibody for AML

The EU Approves New Treatment for a Rare Pediatric Cancer

UK Upstart to sign Huge Deal with Takeda in End Run around Antibody Therapies

MorphoSys’ CEO Tells Us What’s Next for Europe’s Antibody Expert

Shire In-Licenses Swiss Antibody for Hemophilia A to Compete with Roche

Epsilogen completes first clinical trial of IgE antibody to treat cancer

Novartis delivers German Biotech’s 12th Antibody to Clinics

Next-Gen Cancer Antibody Technology from Germany enters the Clinic

What Cancer Therapies did European Biotechs Showcase at ASCO 2017?

The Billion-Euro European Biotech Companies in 2022

M&As: what’s up with the ADC buying spree?

French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!